Bulletin from the extraordinary general meeting of D. Carnegie & Co AB

The extraordinary general meeting of D. Carnegie & Co AB (publ) (the ”Company”)
held on 23 March 2016 passed the following resolutions:
Resolution regarding authorization for the board of directors to resolve to
issue new shares of series B
The extraordinary general meeting of the Company today resolved, in accordance
with the proposal from the board of directors, to authorize the board of
directors for the period up to the next annual general meeting to, whether on
one or several occasions, against cash payment, or otherwise on special
conditions, resolve to issue: a) new shares of series B without preferential
rights for the shareholders; provided however that such issue of shares must
never result in the Company’s issued share capital or the number of shares of
series B in the Company at any time, being increased by more than a total of 10
per cent; and, b) new shares of series B with preferential rights for the
shareholders, provided however that such issue of shares must never result in
that the number of shares of series B in the Company at any time, being
increased by more than 10,000,000 new shares or that any such issue result in
the Company’s share capital exceeding the Company’s maximum allowed share
capital as set out in the articles of association.

The Company has appointed SEB and ABG Sundal Collier as advisors for a planned
share issue on the basis of the authorization.
For more information, please contact:
Ulf Nilsson, CEO, D. Carnegie & Co

+46 (0)8 – 121 317 25

Knut Pousette, Chairman of the board of directors, D. Carnegie & Co
+46 (0)8 – 121 317 00
This information is such information that D. Carnegie & Co AB (publ) is required
to disclose pursuant to the Swedish Securities Market Act and/or the Swedish
Financial Instrument Trading Act. The information was released for publication
on 23 March 2016 at [●] [a.m./p.m.] (CET).